Dose Administration Aids
A MedsCheck service is provided within a Community Pharmacy and consists of a review of a Patient’s medicines to improve the Patient’s understanding of their medicines and ultimately, Patient outcomes. The service aims to support self-management by evaluating a Patient’s knowledge about their medicines, addressing any problems the Patient has identified with their medicines, and advising the Patient about the best way to utilise and store their medicines. A Diabetes MedsCheck builds on the format of a MedsCheck service while focusing specifically on the Patient’s experience with type 2 diabetes. A Diabetes MedsCheck likewise includes a discussion between the Pharmacist and Patient. It seeks to assist the Patient in understanding their diabetes medicines, improve their utilisation of self-monitoring devices and improve blood glucose parameters, thereby reducing the risk of developing complications associated with diabetes. Service Providers must gain consent from Patients to perform a MedsCheck or Diabetes MedsCheck service, and for the collection of data that will be provided to the Pharmacy Programs Administrator.
To be eligible to become an Approved MedsCheck Service Provider and participate in the MedsCheck Program, a Pharmacy must:
A Patient who is eligible to receive a MedsCheckservice will meet the following criteria:
A Patient who is eligible to receive a Diabetes MedsCheck service will meet the following criteria:
Barriers to ‘timely access’ to existing diabetes education/health services should be determined by the Registered Pharmacist based on the Patient’s specific needs and may include:
Diabetes MedsCheck Services are not available to in-Patients of public or private hospitals, day hospital facilities, transitional care facilities, to residents of an Aged Care Facility or Patients in a correctional facility. The Pharmacist should take reasonable steps to determine if the Patient is eligible for a MedsCheck or Diabetes MedsCheck service.
Service Providers are subject to a service cap of 20 MedsCheck and/or Diabetes MedsCheck services per calendar month. The service cap applies to the Service Provider regardless of the number of Pharmacists who provide the service. This cap applies to any combination of MedsCheck or Diabetes MedsCheck services provided.
MedsCheck and Diabetes MedsCheck services must be claimed online via the Pharmacy Programs Administrator Portal by the end of the calendar month following the services (e.g. services undertaken in May must be claimed by 30 June). Claims submitted outside this timeframe will not be paid and cannot be resubmitted.
Service Providers will receive payments for MedsCheck and Diabetes MedsCheck services provided and claimed within the claiming period as set out in the following table:
|Fee (per Patient)||Description|
|$66.53||Initial MedsCheck service|
|$99.79||Initial Diabetes MedsCheck service|
Note that for a service provided as part of the MedsCheck and Diabetes MedsCheck Program, Patients cannot be charged any additional or gap fees for the service.
Service Providers participating in Community Pharmacy Programs must keep all relevant records for seven years after the provision of funded services. These records may be electronic or hard copy and include all claim forms, notes and records of the consultation, or other records generated in the provision of the service. The Australian Government Department of Health is responsible for auditing the delivery of the Community Pharmacy Programs. Anomalies observed by the Pharmacy Program Administrator will be reported to the Department. If an audit is conducted, the Service Provider will be required to produce supporting documentation within a specified timeframe. Service Providers found to be in breach of the Program Rules may be subject to penalties.
MedsChecks and Diabetes MedsChecks should, where possible, be undertaken face-to-face in the pharmacy.
However, in response to the COVID-19 pandemic, from 21 April 2020 MedsChecks and Diabetes MedsChecks, may temporarily be offered via telehealth where a Patient meets any of the following eligibility criteria:
Telehealth services (also known as video conferencing services) are the preferred approach for substituting a face-to-face consultation. However, if video is not available, Service Providers will also be able to offer audio-only services via telephone.
In the case where a Patient is isolating themselves at home on the advice of a medical practitioner for confirmed COVID-19 cases, it is recommended that the Service Provider considers whether or not a service is still clinically appropriate and, if so, the service may be undertaken remotely. It should be noted that a patient’s ability to participate in a service may be impacted and this should be taken into consideration.
PSA resources about telehealth arrangements can be found here.
A patient should always be offered the option to have the MedsCheck or Diabetes MedsCheck within the pharmacy first.
In response to the COVID-19 pandemic, telehealth services, also known as video conferencing services, may temporarily be offered where a Patient meets the following eligibility criteria:
If video conferencing is not available, you may offer audio-only services to the patient.
You must still ensure all aspects of a MedsCheck/Diabetes MedsCheck are undertaken, such developing an Action Plan with the patient, providing them with a copy of the Action Plan and their Medication Profile and uploading a record of the MedsCheck/Diabetes MedsCheck to their My Health Record (if they have one).
If the patient does not meet any of the above eligibility criteria then the MedsCheck/Diabetes MedsCheck must still be undertaken in the pharmacy in order to be claimed under the program.
Yes. You must not pass on the patient’s personal information (i.e submit a claim to the PPA) if you do not have their verbal or written consent to do so.
A consent form is available under the Resources section below that covers both types of consent.
Some patients may prefer to read the consent form and electronically sign or print and sign the form and email it back to the pharmacy rather than provide verbal consent. It is the patient’s choice whether they provide verbal or written consent.
Please refer to the Portal User Guide – MedsCheck and Diabetes MedsCheck that is available from the Downloads section of this page.
Please see the Program Rules available from the Downloads section of this page.
A total of 20 services per Pharmacy per calendar month. This can comprise any combination of MedsCheck and Diabetes MedsCheck Services so long as the total number of these services does not exceed 20.
There are no restrictions placed on the make-up of those 20 services.
From 1 March 2020 the collection of Health Outcome Data is not required. Data can still be collected and submitted through the portal but no payment will be made to you for the collection of this data.
From 1 March the collection of Health Outcome Data is not required. Data can still be collected and submitted through the portal but no payment will be made to you for the collection of this data.
Pharmacists are allowed to offer the service to Patients who are ineligible for a funded MedsCheck Service, or where the cap has been reached, and they may charge the Patient for this service.
Claims are due at the end of the calendar month after the service was completed, e.g. a claim for a service completed on 15 February 2019 should be submitted by 31 March 2019.
So long as the claim is submitted within the timeframe (the end of the calendar month after the service was completed), you can submit as many claims as you like.
No; however, the consent form should be retained for seven years to support any claim for payment.
No. An Action Plan should be developed with the Patient and should list specific goals agreed to during the MedsCheck. See the PSA MedsCheck Guidelines in the Downloads section for more information on what should be in an Action Plan. An electronic or paper copy of the Action Plan should be retained for seven years for auditing purposes.
Pharmacists are advised to use their professional knowledge and discretion when determining if a Patient is eligible under this criterion. Appropriate documentation should be recorded and stored for audit purposes, which includes justification for Patient eligibility.
Yes. Examples include paracetamol, calcium and vitamin D. While the Patient may not need a prescription for re-supply of non-prescription medicines, the original order should be from a prescriber with a record in the Pharmacy’s dispense history for the Patient.
The component medicines of a combination product may be counted as individual medicines, except for medicines that are almost invariably used together in fixed-dose combinations for clinical reasons e.g. oral contraceptives, hormone replacement therapies and Helicobacter pylori eradication regimens.